2 Reasons Investors Should Not Short SpaceX Stock

SpaceX is described as having a roughly 135x 2025 price-to-sales multiple, highlighting clear overvaluation, but the article argues this is not a compelling short because the company’s Starlink and private launch businesses create strong competitive moats. The piece emphasizes that elevated valuations can persist for long periods, citing Palantir as an example, and warns that shorting SpaceX carries theoretically unlimited risk if the stock keeps rising. Overall, the article is a valuation and positioning commentary rather than a new operating update.

Analysis

The important second-order signal here is not that SpaceX is expensive; it is that the market is still willing to underwrite extreme duration on scarce, infrastructure-like assets with quasi-monopoly characteristics. That tells you investor appetite remains strongest for names where the path to monetization is long but the addressable market is strategically necessary, which is supportive for other private-market adjacencies and late-stage growth comps more than for broad speculative beta.

The clearest public-market read-through is to the short book, not the long book. A high-multiple, product-dominant story can stay structurally bid as long as there is no obvious competitive substitute and no financing event that forces price discovery; in that regime, shorts are paying carry while waiting for a catalyst that may be years away. That dynamic is especially punitive in crowded factor baskets that are already exposed to “quality growth” and “AI infrastructure” names with similar narrative elasticity.

The contrarian miss is that valuation discipline is less relevant than marginal capital source. If private and crossover capital keeps marking these assets higher, it can compress implied returns for public comparables even without any operational change. In practice, that means the better trade is often relative-value: own the strongest public analogs with visible cash flow conversion and avoid naked shorts in story stocks unless you have a near-term catalyst, a financing overhang, or a product setback to define the clock.

The Palantir mention is the key positioning clue: this is a reminder that expensive winners can remain expensive longer than consensus expects. That creates a nasty asymmetric setup for shorts over the next 1-3 quarters, because upside can be sentiment-driven while downside needs an operational inflection. Until there is evidence of launch delays, demand saturation, or regulatory constraint, the burden of proof stays on the short side.

Key Decisions for Investors

• Avoid initiating a standalone short in PLTR on valuation alone; if expressing the view, use a defined-risk put spread with a 3-6 month horizon so theta/carry does not dominate the thesis.
• Relative-value: long NVDA vs. short a basket of unprofitable high-multiple software/space-adjacent names for 1-2 quarters; the goal is to isolate secular AI capex demand while reducing multiple-risk exposure.
• If looking for mean reversion, wait for a catalyst-based entry only after a 10-15% drawdown in the target name or after evidence of growth deceleration; otherwise expected short carry is unfavorable.
• Use PLTR as a sentiment proxy: if it holds new highs on no fundamental news, that is a signal to trim short exposure across crowded growth baskets, not add to it.
• For investors wanting upside convexity, prefer call spreads in the strongest public analogs to private-market winners rather than chasing illiquid private-market proxies with unbounded valuation risk.